SCHEMBL5159760

SCHEMBL5159760

CCOC(=O)c1cc2c(OC)cc3ccccc3c2n1CC1CCCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.49
PLA2G2A P14555 3/20 0.48
ALDH1A1 P00352 3/20 0.44
NPSR1 Q6W5P4 2/20 0.44
PLA2G1B P04054 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CNR1 P21554 6/20 0.42
MAPK8 P45983 1/20 0.40
AR P10275 1/20 0.39
MEN1 O00255 2/20 0.39
ATM Q13315 1/20 0.39
NOD2 Q9HC29 1/20 0.39
NOD1 Q9Y239 1/20 0.39
TP53 P04637 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5162888 0.82 PLA2G2A (0.48) PLA2G2AALDH1A1NPSR1PLA2G1BATG4B
SCHEMBL5160134 0.81 KMT2A (0.55) KMT2APLA2G2AALDH1A1PLA2G1BTDP1
SCHEMBL5159835 0.79 PLA2G2A (0.46) PLA2G2AALDH1A1NPSR1PLA2G1BATG4B
SCHEMBL14608289 0.77 KMT2A (0.48) KMT2APLA2G2AALDH1A1PLA2G1BTDP1
SCHEMBL5158136 0.77 KMT2A (0.48) KMT2APLA2G2AALDH1A1PLA2G1BTDP1
SCHEMBL5158958 0.74 PLA2G2A (0.66) KMT2APLA2G2AALDH1A1NPSR1PLA2G1B
SCHEMBL14608171 0.73 KMT2A (0.46) KMT2APLA2G2AALDH1A1PLA2G1BTDP1
SCHEMBL26670751 0.72 TP53 (0.42) KMT2AALDH1A1MEN1NOD2NOD1
SCHEMBL28305009 0.72 NOD2 (0.66) KMT2AALDH1A1NPSR1TDP1L3MBTL1
SCHEMBL26660771 0.72 NOD2 (0.45) KMT2AMEN1NOD2NOD1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1358156-B1 BENZ(G) INDOLES AND THEIR USE AS SPLA2 INHIBITORS LILLY CO ELI (US) 2007-02-21 EP disclosed
EP-1358156-B1 BENZ(G) INDOLES AND THEIR USE AS SPLA2 INHIBITORS LILLY CO ELI (US) 2007-02-21 EP disclosed
US-6916840-B2 Spla2 inhibitors ELI LILLY AND COMPANY (US) 2005-07-12 US disclosed
US-20040063967-A1 Novel spla2 inhibitors BEIGHT DOUGLAS WADE (US) 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063967-A1 Novel spla2 inhibitors PLA2G12A, SPINT2, PLA2G4A KMT2A 2957/4885PLA2G2A 16/4885ALDH1A1 2761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.